Solvay Weathers Q2 Storm, Signals Growth with Rare Earths Investment

BRUSSELS, Belgium – July 29, 2026 – Chemical giant Solvay reported a challenging second quarter, with revenues and profits hit by a combination of weak commodity pricing and geopolitical turmoil. However, in a clear signal of confidence, the company reaffirmed its full-year financial guidance, pointing towards a significant second-half recovery and a long-term strategic pivot into the high-demand rare earths market. Investors responded positively, pushing shares up over 4% in pre-market trading, choosing to focus on the future outlook rather than the quarter's headwinds.

Navigating a Turbulent Quarter

Solvay's Q2 2026 results painted a picture of a company navigating significant external pressures. Underlying net sales fell to €1,031 million, a 7.4% organic decline compared to the same period last year, coming in slightly below market consensus. The drop was driven primarily by a 5.3% decrease in volumes and a 2.2% dip in pricing.

The impact on profitability was more pronounced. Underlying EBITDA for the quarter was €187 million, a steep 19.5% organic decline year-over-year. This squeezed the company's EBITDA margin down to 18.1% from 20.9% in Q2 2025. According to the company, the profit decline was driven equally by two major factors: the ongoing conflict in the Middle East and a tough comparison against Q2 2025, which included a one-off gain of approximately €20 million.

Free cash flow, a key indicator of financial health, turned negative at -€11 million for the quarter, a stark reversal from the positive €54 million generated a year ago. Despite this, the company maintained a positive cash flow of €15 million for the first half of the year.

In response to the challenging environment, Solvay has intensified its focus on internal efficiencies. The company's structural cost savings program delivered another €26 million in Q2, primarily through operational excellence initiatives at its manufacturing plants. This brings the total cumulative savings since 2024 to €288 million, well on track to meet the year-end target of around €300 million. This disciplined cost management is a critical lever helping the company mitigate external pressures and protect its bottom line.

Geopolitical Headwinds and Supply Chain Realities

The Q2 report served as a stark case study on the vulnerability of global supply chains to geopolitical instability. A significant portion of Solvay's performance dip was directly attributed to the temporary shutdown of its Peroxides plant in Jubail, Saudi Arabia, since mid-March due to the regional conflict. This single event accounted for roughly half of the year-on-year EBITDA decline, demonstrating the tangible financial cost of geopolitical risk.

In the earnings release, CEO Philippe Kehren acknowledged the difficult environment. “Our second quarter results reflect the continued challenging economic environment,” he stated. “The conflict in the Middle East had a negative impact on our performance, mainly due to the temporary shutdown since mid-March of our Peroxides plant in the region.”

The company’s ability to reaffirm its full-year guidance hinges critically on the anticipated restart of this plant during the third quarter. The incident underscores a broader challenge for the entire chemical industry, where complex, globalized production networks can be easily disrupted. While companies are becoming more adept at managing these risks, the Solvay example shows that even temporary shutdowns can have an immediate and material impact on financial results.

Despite the setback, Kehren projected confidence in the company's direction. “Despite these headwinds, our teams remain focused on the transformation of our company... We take the necessary actions to improve our operations and deliver on our guidance, while looking at opportunities to reinforce and expand our most promising activities in the future.”

A Strategic Bet on European Rare Earths

While grappling with immediate operational challenges, Solvay is simultaneously making a significant long-term strategic play. The company announced the approval of an additional €15-20 million investment to expand its rare earths separation capacities at its facility in La Rochelle, France. This move is a powerful growth signal, indicating a deliberate pivot toward high-value, strategic materials.

The La Rochelle plant is already one of the largest rare earths separation facilities outside of China. This new investment will allow Solvay to begin industrial-scale separation of dysprosium (Dy) and terbium (Tb) in autumn 2026. These so-called "heavy" rare earths are critical components in the high-performance permanent magnets used in electric vehicle motors and wind turbines, placing Solvay at the heart of the green energy transition.

This investment is not just a business decision; it’s a geopolitical one. Europe is heavily dependent on China for the supply of processed rare earth elements, a vulnerability that policymakers in Brussels are keen to address. By bolstering its separation capabilities, Solvay is positioning itself as a key player in Europe's quest for strategic autonomy in critical raw materials. The move, supported by new customer commitments, aims to build a more resilient European supply chain and reduce reliance on non-European sources.

Balancing the Books for Future Growth

Even with the challenging quarter, Solvay's financial foundation appears stable enough to support its strategic ambitions. The company's underlying net debt stood at €1.8 billion at the end of June, pushing its leverage ratio temporarily to 2.3x net debt-to-EBITDA following dividend payments. However, management expects this ratio to return to its target of approximately 2.0x by the end of the year, signaling confidence in improved earnings and cash flow in the second half.

That confidence is most clearly expressed in the reaffirmed full-year guidance. Solvay still expects to generate an underlying EBITDA between €770 million and €850 million and, crucially, a free cash flow of at least €200 million. Achieving this cash flow target after a negative Q2 and a modest €15 million in H1 will require a powerful operational turnaround in the latter half of the year, heavily reliant on the Saudi plant's restart and sustained market improvements.

This commitment to strong cash generation, even while allocating around €300 million for capital expenditures in 2026, shows a disciplined approach to capital. It demonstrates management's belief that it can navigate short-term volatility without sacrificing the strategic investments, like the one in La Rochelle, that are essential for future growth.